Indoco Remedies gets nod to market generic diabetes drug from USFDA

Indoco Remedies gets nod to market generic diabetes drug from USFDA
Indoco said it plans to produce the medication at its manufacturing facility in Goa. Representational Image: Pixabay

Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication.

The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.

The company's product is the generic equivalent of Invokamet tablets.

Indoco said it plans to produce the medication at its manufacturing facility in Goa.

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus.

"This milestone underscores our commitment to bringing affordable and effective treatment options to patients managing type 2 diabetes," Indoco Remedies MD Aditi Panandikar said.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/market-news/news-short-term-investment-ideas-stocks-to-buy-for-15-days-axis-direct-recommends-fortis-healthcare-aegis-logistics-check-targets-334316

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

https://www.zeebiz.com/personal-finance/photo-gallery-ppf-interest-rate-maturity-retirement-corpus-planning-calculator-how-to-get-inr-rs-72000-month-tax-free-income-from-public-provident-fund-calculations-80c-tax-benefits-333983

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-long-it-will-take-to-build-rs-5-crore-corpus-target-with-inr-5000-10000-and-15000-monthly-investment-retirement-planning-with-sip-calculator-market-linked-return-334417

Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-fd-and-senior-citizen-savings-scheme-interest-rate-calculator-know-which-guaranteed-return-will-provide-better-income-quarterly-on-rs-20-lakh-investment-in-five-years-calculations-inside-334063

SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?

https://www.zeebiz.com/personal-finance/photo-gallery-rs-3500-monthly-sip-for-35-years-vs-rs-35000-monthly-sip-for-16-years-which-can-give-you-higher-corpus-in-long-term-compound-interest-benefits-mutual-fund-return-calculator-retirement-planning-334249

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

https://www.zeebiz.com/personal-finance/news-rs-1111-monthly-sip-for-40-yrs-11111-for-20-yrs-or-22222-for-10-years-which-works-best-at-same-expected-return-334395

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-soon-will-monthly-sip-of-rs-11000-reach-rs-8-crore-corpus-target-retirement-financial-planning-with-sip-calculator-334296

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-444-day-special-fd-vs-pnb-400-day-fixed-deposit-interest-rate-maturity-calculator-what-will-general-senior-citizens-get-in-return-on-inr-rs-350000-700000-investments-in-guaranteed-fixed-income-333262

SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?

Written By: PTI
Updated: Thu, Jun 06, 2024
04:53 PM IST
New Delhi, PTI
RELATED NEWS
Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug
Alembic Pharma gets US health regulator FDA's nod for scalp psoriasis treatment drug Alembic Pharma gets US health regulator FDA's nod for scalp psoriasis treatment drug
Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x